GMP Facilities for Manufacturing of Advanced Therapy Medicinal Products for Clinical Trials: An Overview for Clinical Researchers

Current Gene Therapy

Volumn 10, Issue 6, 2010, Pages 508-515

  Alici, Evren ^a   Blomberg, Pontus ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ATMP; Cell therapy; Clean rooms; Clinical grade; Gene therapy; GMP; Regulations

Indexed keywords

ARTICLE; BUDGET; CELL THERAPY; CLEANING; CLINICAL RESEARCH; CLINICAL TRIAL; EQUIPMENT; EUROPEAN UNION; GENE; GENE THERAPY; GOOD MANUFACTURING PRACTICE; HEALTH CARE ORGANIZATION; HOSPITAL; HUMAN; MONITORING; STORAGE; WASTE WATER MANAGEMENT; WORKFLOW;

BIOMEDICAL RESEARCH; CELL TRANSPLANTATION; CHEMISTRY, PHARMACEUTICAL; CLINICAL TRIALS AS TOPIC; EUROPE; EUROPEAN UNION; GENE THERAPY;

EID: 78651289534     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652310793797757     Document Type: Article

References (21)

1. Jones S, Levine H. Impact of the EU Clinical Trials Directive andother recent regulatory changes on the manufacture ofbiopharmaceuticals. Preclinica 2004; 2(5): 301-4.
2. Burger S. Current regulatory issues in cell and tissue therapy. Cytotherapy 2003; 5(4): 289-98.
3. McMannis J, Champlin R. Role of the GMP facility for adoptiveimmunotherapy. Cytotherapy 2002; 4(4): 329-31.
4. Dietz A, Padley D, Gastineau D. Infrastructure development forhuman cell therapy translation. Clin Pharmacol Ther 2007; 82(3): 320-4.
5. Hengster P, Hermann M, Pirkebner D, Draxl A, Margreiter R. Isletisolation and GMP, ISO 9001: 2000: what do we need--a 3-yearexperience. Transplant Proc 2005 Oct; 37(8): 3407-8.
6. Wall D, Prince H. Regulation of cellular therapies: the Australianperspective. Cytotherapy 2003; 5(4): 284-8.
7. Burger S. Design and operation of a current good manufacturingpractices cell-engineering laboratory. Cytotherapy 2000; 2(2): 111-22.
8. Anderson W. Making clinical grade gene therapy vectors. Hum Gene Ther 1994; 5(8): 925-6.
9. Community E. Directive 2001/83/EC of the European Parliamentand of the Council of 6 November 2001 on the Community coderelating to medicinal products for human use. Off Journ 2001; L311: 67.
10. Europe Co. European Pharmacopoeia. 1997.
11. Community E. Directive 2004/23/EC of the European parliamentand of the council of 31 March 2004 on setting standards of qualityand safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. Off Journ Eur Union 2004: 48-58.
12. Community E. Regulation (EC) no 1394/2007 of the Europeanparliament and of the council of 13 November 2007 on advancedtherapy medicinal products and amending Directive 2001/83/ECand Regulation (EC) No 726/2004. Official Journ Eur Union 2007: 121-37.
13. Brévignon-Dodin L, Singh P. ATMP in practice: Towards a newindustry landscape in tissue engineering. J Comm Biotech 2008; 15(1): 59-65.
14. Community E. EC guide to good manufacturing practice revision toannex 1 title: Manufacture of Sterile Medicinal Products Note:manufacture of sterile medicinal products. Official J Eur Union 2003.
15. Signore A, Jacobs T. Good design practices for GMPpharmaceutical facilities. Drugs and the Pharmaceutical Sciences. New York: Informa healthcare; 2005. p. 1-7.
16. F. D. A. 21 CFR Parts 16, 1270, and 1271 Current Good Tissue Practice for Human Cell, Tissue, and Cellular and Tissue-Based Product Establishments; Inspection and Enforcement; Final Rule. Federal Register. 2004; 69: 68612-88.
17. Commission E. EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use. Practice 2008. p. 1-16.
18. Federal Standard U. 209E. Airborne particulate cleanliness classesin cleanrooms and clean zones. 1992.
19. Xu T. Characterization of minienvironments in a cleanroom:Assessing energy performance and its implications. Building Environ 2008; 43(9): 1545-52.
20. Giordano R, Lazzari L, Rebulla P. Clinical grade cell manipulation. Vox sanguinis. 2004; 87(2): 65-72.
21. Gee A. Cell Therapy: CGMP Facilities and Manufacturing. In: Gee A, editor. 1 ed: Springer Verlag; 2009. p. 185-204.